Mirae Asset Global Investments Co., Ltd. Sutro Biopharma, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$3.27 - $5.65 $143,942 - $248,707	44,019 New	44,019 $248,000
Q3 2023 Oct 26, 2023	BUY	$3.29 - $4.9 $184 - $274	56 Added 0.12%	45,441 $157,000
Q2 2023 Aug 10, 2023	SELL	$4.25 - $5.88 $34,947 - $48,351	-8,223 Reduced 15.34%	45,385 $211,000
Q1 2023 May 04, 2023	BUY	$4.48 - $8.45 $153,368 - $289,277	34,234 Added 176.7%	53,608 $247,000
Q4 2022 Feb 09, 2023	BUY	$5.41 - $8.08 $827 - $1,236	153 Added 0.8%	19,374 $156,000
Q3 2022 Nov 10, 2022	BUY	$5.17 - $7.11 $29,546 - $40,633	5,715 Added 42.31%	19,221 $106,000
Q2 2022 Jul 26, 2022	BUY	$3.41 - $8.95 $46,055 - $120,878	13,506 New	13,506 $70,000

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $105M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.